AAVrh.10cuARSA / European Leukodystrophy Association, REGENXBIO, Public Assistance - Paris Hospitals - LARVOL DELTA

TG-MLD: Intracerebral Gene Therapy for Children with Early Onset Forms of Metachromatic Leukodystrophy (clinicaltrials.gov) - P1/2 | N=5 | Completed | Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Active, not recruiting ➔ Completed

Trial completion • Gene Therapies • Metabolic Disorders

TG-MLD: Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy (clinicaltrials.gov) - P1/2; N=5; Active, not recruiting; Sponsor: Institut National de la Santé Et de la Recherche Médicale, France; Trial completion date: Apr 2019 ➔ May 2029

Clinical • Trial completion date • Gene Therapies • Immunology • Metabolic Disorders • MRI